The approach to small vessels in the era of drug-eluting stents

Reviews in Cardiovascular Medicine

Volumn 6, Issue SUPPL. 1, 2005, Pages

  Holmes Jr , David R ^a   Kereiakes, Dean J ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b CHRIST HOSPITAL   (United States)

Author keywords

Drug eluting stent; Late loss; Sirolimus; Small vessels; Stent design

Indexed keywords

METAL; POLYMER; RAPAMYCIN;

ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY BLOOD VESSEL; DEVICE; DRUG ELUTING STENT; HUMAN; META ANALYSIS; RESTENOSIS; REVASCULARIZATION; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR DISEASE;

BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ARTERIOSCLEROSIS; HUMANS; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS; STENTS; TIME FACTORS;

EID: 13644265291     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Dodge JT, Brown BG, Bolson EL, et al. Lumen diameter of normal human coronary arteries. Influence of age, sex, anatomic variation, and left ventricular hypertrophy or dilation. Circulation 1992;86:232-246.
2. Foley DP, Melkert R, Serruys PW. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty. Circulation. 1994;90:1239-1251.
3. Schunkert H, Harrell L, Palacious IF. Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization. J Am Coll Cardiol. 1999;34:40-48.
4. Ho KKL, Senerchia C, Rodriguez O, et al. Predictors of angiographic restenosis after stenting: pooled analysis of 1197 patients with protocol-mandated angiographic follow-up from 5 randomized stent trials [abstract]. Circulation. 1998,98:I-362.
5. Moreno R, Fernandez C, Alfonso F. Coronary stenting versus balloon angioplasty in small vessels. J Am Coll Cardiol. 2004;43:1964-1972.
6. Hausleiter J, Kastrati A, Mehilli J, et al. Predictive factors for early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries. J Am Coll Cardiol. 2002;40:882-889.
7. Pache J, Kastrati A, Mehilli J, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) Trial. J Am Coll Cardiol. 2003;41: 1283-1288.
8. Kastrati A, Mehilli J, Dirschinger J, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) Trial. J Am Coll Cardiol. 2001;2816-2821.
9. Kereiakes DJ. Coronary small-vessel stenting in the era of drug elution. Rev Cardiovasc Med. 2004;5(suppl 2):S34-S45.
10. Schampaert E, Cohen EA, Schluter M, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol. 2004;43:1110-1115.
11. Schofer J, Schluter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS). Lancet. 2003; 362:1093-1099.
12. Lemos PA, Arampatzis CA, Saia F, et al. Treatment of very small vessels with 2.25-mm diameter sirolimus-eluting stents (from the RESEARCH Registry). Am J Cardiol. 2004;93: 633-636.
13. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-1323.
14. Ardissino D, Cavallini C, Bramucci E, et al for the SES-SMART Investigators. Sirolimus-eluting versus uncoated stents for prevention of restenosis in small arteries: a randomized trial. JAMA. 2004;292:2727-2734.